CION Cancer Clinics
Conventional TACE vs drug-eluting bead TACE: what is the difference? | CION Cancer Clinics
Both are chemoembolisation: chemotherapy sent into the tumour's artery, which is then blocked. Conventional TACE carries the drug in an oily dye; bead TACE loads it into tiny beads that release it slowly. Trials found tumour control broadly similar, with beads letting less drug into the body. This page explains the difference, who TACE does not suit, and how the choice is made. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
On this page
- What is the difference between conventional TACE and bead TACE?
- How do the two kinds of TACE compare?
- How does your team decide which kind of TACE to use?
- Is the newer bead TACE always the better choice?
- Who should not have either kind of TACE?
- What this page cannot tell you
- Common questions about conventional and bead TACE
The short answer
What is the difference between conventional TACE and bead TACE?
Both are TACE, which means chemoembolisation: chemotherapy is sent straight into the artery feeding a liver tumour, and that artery is then blocked. The difference is how the chemotherapy travels. In conventional TACE it is mixed with an oily dye and followed by blocking particles. In drug-eluting bead TACE, often written DEB-TACE, it is soaked into tiny beads that block the artery and release the drug slowly.
Who this page is for
This page is about primary liver cancer, hepatocellular carcinoma (HCC), the cancer that starts in liver cells. It is usually written for someone at the intermediate stage, called BCLC stage B, who has been offered TACE and told there are two kinds. If the cancer in your liver spread there from the bowel, breast or elsewhere, the choices are different and start with the original cancer.
Does one work better?
The large comparisons so far have found the two broadly similar at shrinking or controlling the tumour. Bead TACE lets less of the drug spill into the rest of the body, so some people have fewer drug side effects. Neither has clearly been shown to help people live longer than the other. The choice usually rests on the tumour, your liver, what the interventional radiologist uses well, and cost.
Both versions block the blood supply. That blocking is the main way TACE works.Side by side
How do the two kinds of TACE compare?
What the team weighs
How does your team decide which kind of TACE to use?
The tumour board looks at the whole picture, not at one technique on its own. These are the things that usually tip the choice.
Your liver function
TACE stresses the healthy liver around the tumour. If your Child-Pugh score or bilirubin is borderline, the team may lean towards the gentler drug exposure of beads, or towards a smaller, more targeted treatment.
The tumour's size and spread
Several small tumours, one large one, or tumours in both halves of the liver can each suit a different approach. The scan pattern matters more than the name of the technique.
Your heart and general health
The usual drug in both is doxorubicin, which can strain the heart. If you have heart trouble, less drug in the bloodstream is a reason some teams prefer beads.
The radiologist's experience
Results depend heavily on the skill of the interventional radiologist. A team that does one version very well is usually a safer choice than a switch to the other.
Cost and cover
Beads add to the materials bill, and schemes and insurers differ in what they pay for. Ask early so cost does not decide the matter at the last minute.
CION coordinates TACE through NABH-accredited partner hospitals; your team will tell you where it takes place.Not sure whether this applies to you?
Ask an oncologistCommonly believed
Is the newer bead TACE always the better choice?
Newer and dearer does not mean more effective. The trials that compared them found tumour control broadly similar. Beads mainly change how much of the drug reaches the rest of your body, which matters more for some people than others.
Both versions can bring pain, fever and nausea for a few days, known as post-embolisation syndrome. That comes from blocking the blood supply, which both do. Bead TACE may reduce drug effects such as hair thinning, not the blocking effects.
Conventional TACE is a standard, guideline-backed treatment used around the world. Choosing it for cost is a reasonable decision, and it is better than delaying treatment while money is arranged.
TACE is often repeated. If one session caused trouble or the tumour did not respond well, the team can change the technique, the drug or the plan next time.
Who this does not suit
Who should not have either kind of TACE?
The bead question only matters if TACE itself is safe for you. Neither kind suits everyone, and changing the technique does not make an unsafe TACE safe.
When the liver is too weak
If the liver is already failing, with deep jaundice, fluid in the abdomen that is hard to control, or confusion from liver disease, the blocking step can push it into failure. This is why the team checks Child-Pugh, bilirubin and your overall fitness first. The page on when TACE is not safe goes through this in detail.
When the main portal vein is blocked by tumour
The healthy liver depends on the portal vein for much of its blood. If tumour has blocked the main vein, cutting off the artery as well can starve normal liver. Other options, such as TARE or tablets and immunotherapy, are usually considered instead.
When the cancer has spread beyond the liver
TACE treats the liver only. Once cancer is in the lungs, bones or lymph nodes, treatment through the whole body usually comes first.
When something smaller would do
A single small tumour may be better treated by removal or ablation, which aim for a curative result. TACE is not the first choice there.
Being straight with you
What this page cannot tell you
It cannot tell you which kind of TACE is right for your tumour. That depends on your scans, your blood results and your liver, reviewed together by the people treating you. Two patients with the same stage can reasonably be given different versions.
It cannot predict how you will respond
Response is judged on the scan after treatment, not in advance. Some tumours shrink well after one session; others need several, and some stop responding. Nobody can tell you beforehand which you will be.
The evidence has gaps
Most comparison trials were done outside India, in patients chosen carefully, and the techniques have changed since. Where the evidence is thin, your team is using judgement as well as data, and it is fair to ask them why they chose the version they did.
If you have been offered TACE and want a second look at the plan, CION's tumour board can review your scans and reports.Questions we are asked
Common questions about conventional and bead TACE
Is DEB-TACE the same as TACE?
Yes, it is one kind of TACE. Both send chemotherapy into the tumour's artery and block it. DEB-TACE simply carries the drug inside small beads instead of an oily mixture. When a report just says TACE, ask which version was used, because it helps later doctors read your follow-up scans.
Which kind has fewer side effects?
Bead TACE usually lets less drug into the bloodstream, so drug side effects such as tiredness and hair thinning may be milder. Pain, fever and nausea in the first days come from the blocked blood supply and happen with both. Liver strain is possible with either.
Is bead TACE available in Hyderabad?
Both versions are offered by interventional radiology teams in Hyderabad, though not every hospital stocks beads. CION coordinates TACE through accredited partner hospitals and will tell you which version the radiologist plans and where the procedure takes place.
How much more does bead TACE cost?
The beads add to the materials cost, and the difference varies by hospital and by how many vials are needed. Ask for a written, itemised estimate for both versions. The TACE cost page explains what builds the bill and how schemes may help.
Can I ask for bead TACE if I was offered conventional?
You can ask, and the team should explain its reasons. Often the answer rests on your liver, your heart or the radiologist's experience. If the reasons are clinical, they matter more than the label. If it comes down to cost, say so openly so options can be discussed.
Does either kind make the cancer go away for good?
TACE is usually given to control the cancer, not to remove it completely, though in some people it shrinks tumours enough for surgery, ablation or a transplant to be considered. Your team will say plainly whether the aim is control or a step towards a curative treatment.
Will I need more than one session?
Many people do, with either version. The next session is planned after a scan shows how the tumour responded and how your liver coped. The page on how many TACE sessions explains how that decision is made.
Who should I speak to before deciding?
Your medical oncologist and the interventional radiologist who will do the procedure, ideally after a tumour board review. Bring your latest scan, blood reports and a list of medicines. Call the CION helpline if you want those reviewed before you decide.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Embolization Therapy for Liver Cancer
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- Cancer Research UK — Treatment for liver cancer
- American Cancer Society — Treatment of Liver Cancer, by Stage
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Offered TACE and unsure which kind is right for you?
Send us your scans and blood reports and our tumour board can review the plan with you. One helpline serves every CION centre.